Efficacy evaluation of online lymphoedema prevention support program
Not Applicable
Recruiting
- Conditions
- Breast cancer, gynaecologic cancer (cervical cancer, endometrial cancer, ovarian cancer/fallopian tube cancer/peritoneal cancer)
- Registration Number
- JPRN-UMIN000050309
- Lead Sponsor
- Musashino University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who are undergoing treatment or follow-up, and judged by their doctors to be unsuitable for this study at the time of either electronic or written consent; 2. Those who are already diagnosed with lymphoedema at the time of registration for this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The assessment time points of the primary outcome are before program attendance (T0), after completion of the 3rd session (T1:3 months after T0), and after completion of the 4th session (T2: 9 months after T0). The primary outcome is self-efficacy in self-care of lymphoedema prevention.
- Secondary Outcome Measures
Name Time Method 1. Knowledge of self-care for lymphoedema prevention (T0, T1, T2) 2. Anxiety and stress with lymphoedema and self-care (T0, T1, T2) 3. BMI (every month between the 1st and the 4th sessions) 4. QOL (T0, T1, T2) 5. Fatigue (T0) 6. Degree of understanding, enjoyment, and satisfaction with each session (after the 1st, 2nd, 3rd, and 4th sessions) 7. Self-monitoring of self-care (monthly between the 1st and 4th sessions)